Qube Research & Technologies (QRT)’s Cogent Biosciences COGT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.02M	Buy	281,567 +112,369	+66%	+$4.15M	0.01%	1502
2026 Q2	$6.55M	Sell	169,198 -224,802	-57%	-$7.87M	0.01%	1498
2026 Q1	$15.2M	Buy	394,000 +117,272	+42%	+$4.33M	0.02%	1035
2025 Q4	$9.8M	Buy	276,728 +163,070	+143%	+$4.58M	0.01%	1355
2025 Q3	$1.63M	Buy	113,658 +94,756	+501%	+$1.12M	﹤0.01%	2326
2025 Q2	$136K	Buy	+18,902	New	+$105K	﹤0.01%	2984
2024 Q2	–	Sell	-123,017	Closed	-$827K	–	3923
2024 Q1	$827K	Buy	123,017 +5,849	+5%	+$36.2K	﹤0.01%	2255
2023 Q4	$689K	Buy	+117,168	New	+$898K	﹤0.01%	2119
2021 Q4	–	Sell	-38,213	Closed	-$321K	–	2582
2021 Q3	$321K	Sell	38,213 -17,374	-31%	-$133K	﹤0.01%	1458
2021 Q2	$451K	Buy	55,587 +6,546	+13%	+$55.3K	0.01%	1338
2021 Q1	$431K	Buy	+49,041	New	+$472K	0.01%	1266

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Qube Research & Technologies (QRT)'s COGT Position: Q3 2026 in Review

Qube Research & Technologies (QRT) increased its Cogent Biosciences (COGT) stake by 66% in Q3 2026, buying an estimated $4.15M and bringing the position to 281,567 shares worth $9.02M. The position accounts for 0.01% of the portfolio, ranked #1502.

Qube Research & Technologies (QRT) first reported a position in COGT in Q1 2021 and has held it in 11 quarters since. The position peaked at $15.2M in Q1 2026. 202 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

Qube Research & Technologies (QRT) held 281,567 shares of Cogent Biosciences worth $9.02M as of Q3 2026.
Qube Research & Technologies (QRT) bought 112,369 Cogent Biosciences shares in Q3 2026, an estimated $4.15M.
Cogent Biosciences made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1502 holding.
Qube Research & Technologies (QRT) first reported a position in Cogent Biosciences in Q1 2021 and has held it in 11 quarters since.
Qube Research & Technologies (QRT)'s Cogent Biosciences position peaked at $15.2M in Q1 2026.
202 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.